Bio Path Holdings Inc (NASDAQ:BPTH)

1.46
Delayed Data
As of 3:50pm ET
 -0.05 / -3.31%
Today’s Change
1.28
Today|||52-Week Range
4.94
-61.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$11.2M

Company Description

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.

Contact Information

Bio-Path Holdings, Inc.
4710 Bellaire Boulevard
Bellaire Texas 77401
P:(832) 742-1357
Investor Relations:
(832) 742-1369

Employees

Shareholders

Mutual fund holders4.11%
Other institutional2.31%
Individual stakeholders2.28%

Top Executives

Peter H. NielsenChairman, President, CEO, CFO & Treasurer
Ana Tari AshizawaSenior VP-Research, Development & Clinical Design
Anthony PriceSenior VP-Finance, Accounting & Administration
Douglas P. MorrisSecretary & Non-Independent Director
William F. HahneVice President-Clinical Research